Logo image of WEED.CA

CANOPY GROWTH CORP (WEED.CA) Stock Fundamental Analysis

Canada - TSX:WEED - CA1380357048 - Common Stock

2.2 CAD
+0.32 (+17.02%)
Last: 9/29/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, WEED scores 2 out of 10 in our fundamental rating. WEED was compared to 34 industry peers in the Pharmaceuticals industry. The financial health of WEED is average, but there are quite some concerns on its profitability. WEED is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year WEED has reported negative net income.
In the past year WEED has reported a negative cash flow from operations.
In the past 5 years WEED always reported negative net income.
In the past 5 years WEED always reported negative operating cash flow.
WEED.CA Yearly Net Income VS EBIT VS OCF VS FCFWEED.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

With a Return On Assets value of -56.65%, WEED is not doing good in the industry: 82.35% of the companies in the same industry are doing better.
WEED has a worse Return On Equity (-104.81%) than 76.47% of its industry peers.
Industry RankSector Rank
ROA -56.65%
ROE -104.81%
ROIC N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
WEED.CA Yearly ROA, ROE, ROICWEED.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

WEED's Gross Margin of 27.83% is on the low side compared to the rest of the industry. WEED is outperformed by 64.71% of its industry peers.
The Profit Margin and Operating Margin are not available for WEED so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEED.CA Yearly Profit, Operating, Gross MarginsWEED.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

More info and screens

4

2. Health

2.1 Basic Checks

WEED does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WEED has more shares outstanding
The number of shares outstanding for WEED has been reduced compared to 5 years ago.
The debt/assets ratio for WEED has been reduced compared to a year ago.
WEED.CA Yearly Shares OutstandingWEED.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
WEED.CA Yearly Total Debt VS Total AssetsWEED.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of -11.77, we must say that WEED is in the distress zone and has some risk of bankruptcy.
WEED's Altman-Z score of -11.77 is on the low side compared to the rest of the industry. WEED is outperformed by 85.29% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that WEED is somewhat dependend on debt financing.
The Debt to Equity ratio of WEED (0.63) is worse than 64.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Altman-Z -11.77
ROIC/WACCN/A
WACC11.25%
WEED.CA Yearly LT Debt VS Equity VS FCFWEED.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

WEED has a Current Ratio of 3.07. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
WEED's Current ratio of 3.07 is fine compared to the rest of the industry. WEED outperforms 79.41% of its industry peers.
A Quick Ratio of 2.12 indicates that WEED has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.12, WEED is doing good in the industry, outperforming 79.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 2.12
WEED.CA Yearly Current Assets VS Current LiabilitesWEED.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

WEED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.18%, which is quite impressive.
WEED shows a decrease in Revenue. In the last year, the revenue decreased by -4.25%.
Measured over the past years, WEED shows a decrease in Revenue. The Revenue has been decreasing by -7.57% on average per year.
EPS 1Y (TTM)55.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.25%
Revenue 1Y (TTM)-4.25%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%8.94%

3.2 Future

Based on estimates for the next years, WEED will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.29% on average per year.
Based on estimates for the next years, WEED will show a small growth in Revenue. The Revenue will grow by 6.90% on average per year.
EPS Next Y87.72%
EPS Next 2Y39.4%
EPS Next 3Y25.31%
EPS Next 5Y15.29%
Revenue Next Year8.32%
Revenue Next 2Y5.98%
Revenue Next 3Y7.04%
Revenue Next 5Y6.9%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
WEED.CA Yearly Revenue VS EstimatesWEED.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
WEED.CA Yearly EPS VS EstimatesWEED.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WEED. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WEED. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WEED.CA Price Earnings VS Forward Price EarningsWEED.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WEED.CA Per share dataWEED.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

A more expensive valuation may be justified as WEED's earnings are expected to grow with 25.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.4%
EPS Next 3Y25.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WEED!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANOPY GROWTH CORP

TSX:WEED (9/29/2025, 7:00:00 PM)

2.2

+0.32 (+17.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners5.58%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap585.44M
Analysts46.15
Price Target3.77 (71.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-99.21%
Min EPS beat(2)-206.63%
Max EPS beat(2)8.22%
EPS beat(4)1
Avg EPS beat(4)-132.67%
Min EPS beat(4)-231.12%
Max EPS beat(4)8.22%
EPS beat(8)1
Avg EPS beat(8)-186.16%
EPS beat(12)2
Avg EPS beat(12)-180.17%
EPS beat(16)4
Avg EPS beat(16)-164.19%
Revenue beat(2)2
Avg Revenue beat(2)8.61%
Min Revenue beat(2)7.65%
Max Revenue beat(2)9.57%
Revenue beat(4)3
Avg Revenue beat(4)5.74%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)9.57%
Revenue beat(8)5
Avg Revenue beat(8)3.48%
Revenue beat(12)7
Avg Revenue beat(12)1.93%
Revenue beat(16)8
Avg Revenue beat(16)-0.87%
PT rev (1m)0%
PT rev (3m)33.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)41.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.13
P/FCF N/A
P/OCF N/A
P/B 1.2
P/tB 1.64
EV/EBITDA N/A
EPS(TTM)-4.28
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS1.03
BVpS1.84
TBVpS1.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.65%
ROE -104.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.83%
FCFM N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.16%
Cap/Sales 3.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.07
Quick Ratio 2.12
Altman-Z -11.77
F-Score5
WACC11.25%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.25%
EPS Next Y87.72%
EPS Next 2Y39.4%
EPS Next 3Y25.31%
EPS Next 5Y15.29%
Revenue 1Y (TTM)-4.25%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%8.94%
Revenue Next Year8.32%
Revenue Next 2Y5.98%
Revenue Next 3Y7.04%
Revenue Next 5Y6.9%
EBIT growth 1Y47.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.74%
EBIT Next 3Y32.92%
EBIT Next 5Y20.92%
FCF growth 1Y76.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.03%
OCF growth 3YN/A
OCF growth 5YN/A